Laryngeal cancer overview: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Laryngeal cancers arise from squamous cell epithelium of the larynx. Most laryngeal cancers are [[squamous cell carcinoma]]s, reflecting their origin from the [[squamous cell]]s which form the majority of the laryngeal [[epithelium]]. [[Cancer]] can develop in any part of the [[larynx]], but the cure rate is affected by the location of the tumor. For the purposes of tumor [[Cancer staging|staging]], the larynx is divided into three anatomical regions: the [[glottis]] (true vocal cords, anterior and posterior commissures); the supraglottis ([[epiglottis]], [[arytenoids]] and [[aryepiglottic folds]], and [[Vocal folds#False vocal folds|false cords]]); the subglottis. Most laryngeal cancers originate in the [[glottis]]. Supraglottic cancers are less common, and subglottic tumors are least frequent. Laryngeal cancer may spread, either by direct extension to adjacent structures, by [[metastasis]] to regional cervical [[lymph node]]s or more distantly, through the blood stream. Distant metastates to the lung are most common. Laryngeal carcinoma may be classified into more than 14 subtypes based on anatomical and histological characteristics of the tumor. Laryngeal cancer arises from [[squamous cell]]s, which are cells that are normally involved in protection of | Laryngeal cancers arise from squamous cell epithelium of the larynx. Most laryngeal cancers are [[squamous cell carcinoma]]s, reflecting their origin from the [[squamous cell]]s which form the majority of the laryngeal [[epithelium]]. [[Cancer]] can develop in any part of the [[larynx]], but the cure rate is affected by the location of the tumor. For the purposes of tumor [[Cancer staging|staging]], the larynx is divided into three anatomical regions: the [[glottis]] (true vocal cords, anterior and posterior commissures); the supraglottis ([[epiglottis]], [[arytenoids]] and [[aryepiglottic folds]], and [[Vocal folds#False vocal folds|false cords]]); the subglottis. Most laryngeal cancers originate in the [[glottis]]. Supraglottic cancers are less common, and subglottic tumors are least frequent. Laryngeal cancer may spread, either by direct extension to adjacent structures, by [[metastasis]] to regional cervical [[lymph node]]s or more distantly, through the blood stream. Distant metastates to the lung are most common. Laryngeal carcinoma may be classified into more than 14 subtypes based on anatomical and histological characteristics of the tumor. Laryngeal cancer arises from [[squamous cell]]s, which are cells that are normally involved in protection of upper respiratory airways. Genes involved in the pathogenesis of laryngeal cancer include ''[[P16 (gene)|p16]]'', ''[[NOTCH1]]'', ''[[cyclin D1]]'', and ''[[TP53]]''. On gross pathology, flattened plaques, mucosal ulceration, and raised margins of the lesion are characteristic findings of laryngeal cancer. On microscopic histopathological analysis, [[spindle cell]]s, basaloid cells, and nuclear atypia are characteristic findings of laryngeal cancer. Laryngeal carcinoma must be differentiated from laryngeal syphilis, [[lymphoma]], and [[chronic laryngitis]].<ref name=abc>Protocol applies to all invasive carcinomas of the larynx, including supraglottis, glottis, and subglottis.http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Larynx_11protocol.pdf. Accessed on: October 28, 2015.</ref> The prevalence and incidence of laryngeal cancer is approximately 19.5 and 3.3 per 100,000 individuals in the United States, respectively.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> The estimated number of new cases in the United States in 2014 is 12,630 which corresponds to 0.8% of all new cancer cases.<ref name=cancer.gov>[http://seer.cancer.gov/statfacts/html/laryn.html SEER Stat Fact Sheets: Larynx Cancer]</ref> Laryngeal cancer is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH), which means that laryngeal cancer affects less than 200,000 individuals in the US population.<ref name=NIH>{{cite web | title =Annual Report on the Rare Diseases and Conditions Research| url=http://rarediseases.info.nih.gov/ | publsiher=National Institutes of Health | accessdate=2007-03-22}}</ref> In the United Kingdom, 2,369 individuals were diagnosed with laryngeal cancer in 2011.<ref name=UK>[http://www.cancerresearchuk.org/cancer-info/cancerstats/types/larynx/ Cancer research UK]</ref> Common risk factors in the development of laryngeal cancer are smoking tobacco, chewing tobacco, and heavy alcohol consumption.<ref name=aaa>Hypopharyngeal cancer treatment. National Cancer Institute. http://www.cancer.org/cancer/laryngealandhypopharyngealcancer/detailedguide/laryngeal-and-hypopharyngeal-cancer-risk-factors. Accessed on October 26, 2015.</ref> According to the American Cancer Society, screening for laryngeal cancer is not recommended.<ref name=aaa>Can laryngeal and hypopharyngeal cancers be found early? Accessed on October 8, 2015. http://www.cancer.org/cancer/laryngealandhypopharyngealcancer/detailedguide/laryngeal-and-hypopharyngeal-cancer-detection</ref> The optimal therapy for laryngeal cancer depends on the stage at the time of diagnosis. The feasibility of surgery depends on the stage of laryngeal cancer at the time of diagnosis.<ref name=aaa>Management of primary tumor. Surgwiki. http://surgwiki.com/wiki/Otorhinolaryngology. Accessed October 28, 2015</ref> | ||
==Classification== | ==Classification== | ||
Revision as of 20:57, 5 November 2015
|
Laryngeal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Laryngeal cancer overview On the Web |
|
American Roentgen Ray Society Images of Laryngeal cancer overview |
|
Risk calculators and risk factors for Laryngeal cancer overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Laryngeal cancers arise from squamous cell epithelium of the larynx. Most laryngeal cancers are squamous cell carcinomas, reflecting their origin from the squamous cells which form the majority of the laryngeal epithelium. Cancer can develop in any part of the larynx, but the cure rate is affected by the location of the tumor. For the purposes of tumor staging, the larynx is divided into three anatomical regions: the glottis (true vocal cords, anterior and posterior commissures); the supraglottis (epiglottis, arytenoids and aryepiglottic folds, and false cords); the subglottis. Most laryngeal cancers originate in the glottis. Supraglottic cancers are less common, and subglottic tumors are least frequent. Laryngeal cancer may spread, either by direct extension to adjacent structures, by metastasis to regional cervical lymph nodes or more distantly, through the blood stream. Distant metastates to the lung are most common. Laryngeal carcinoma may be classified into more than 14 subtypes based on anatomical and histological characteristics of the tumor. Laryngeal cancer arises from squamous cells, which are cells that are normally involved in protection of upper respiratory airways. Genes involved in the pathogenesis of laryngeal cancer include p16, NOTCH1, cyclin D1, and TP53. On gross pathology, flattened plaques, mucosal ulceration, and raised margins of the lesion are characteristic findings of laryngeal cancer. On microscopic histopathological analysis, spindle cells, basaloid cells, and nuclear atypia are characteristic findings of laryngeal cancer. Laryngeal carcinoma must be differentiated from laryngeal syphilis, lymphoma, and chronic laryngitis.[1] The prevalence and incidence of laryngeal cancer is approximately 19.5 and 3.3 per 100,000 individuals in the United States, respectively.[2] The estimated number of new cases in the United States in 2014 is 12,630 which corresponds to 0.8% of all new cancer cases.[3] Laryngeal cancer is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH), which means that laryngeal cancer affects less than 200,000 individuals in the US population.[4] In the United Kingdom, 2,369 individuals were diagnosed with laryngeal cancer in 2011.[5] Common risk factors in the development of laryngeal cancer are smoking tobacco, chewing tobacco, and heavy alcohol consumption.[6] According to the American Cancer Society, screening for laryngeal cancer is not recommended.[6] The optimal therapy for laryngeal cancer depends on the stage at the time of diagnosis. The feasibility of surgery depends on the stage of laryngeal cancer at the time of diagnosis.[6]
Classification
Laryngeal carcinoma may be classified into more than 14 subtypes based on the anatomical and histological characteristics of the tumor.
Pathophysiology
Laryngeal cancer arises from squamous cells, which are cells that are normally involved in protection of upper respiratory airways. Genes involved in the pathogenesis of laryngeal cancer include p16, NOTCH1, cyclin D1, and TP53. On gross pathology, flattened plaques, mucosal ulceration, and raised margins of the lesion are characteristic findings of laryngeal cancer. On microscopic histopathological analysis, spindle cells, basaloid cells, and nuclear atypia are characteristic findings of laryngeal cancer.
Causes
There are no established direct causes for laryngeal cancer. Common risk factors for laryngeal cancer can be found here.[6]
Differentiating Laryngeal cancer from other Diseases
Laryngeal carcinoma must be differentiated from laryngeal syphilis, lymphoma, and chronic laryngitis.[1]
Epidemiology and Demographics
The prevalence of laryngeal cancer is approximately 19.5 per 100,000 individuals in the United States.[2] The incidence of laryngeal cancer is approximately 3.3 per 100,000 individuals in the United States.[2] The estimated number of new cases in the United States in 2014 is 12,630 which corresponds to 0.8% of all new cancer cases.[3] Laryngeal cancer is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH), which means that laryngeal cancer affects less than 200,000 people in the US population.[4] In the United Kingdom, 2,369 people were diagnosed with laryngeal cancer in 2011.[5]
Risk Factors
Common risk factors in the development of laryngeal cancer are smoking tobacco, chewing tobacco, and heavy alcohol consumption.[6]
Screening
According to the American Cancer Society, screening for laryngeal cancer is not recommended.[6]
Natural History, Complications and Prognosis
If left untreated, laryngeal cancer produces few symptoms early in the course. Once the tumor has expanded from its site of origin, it may obstruct the airway. Common complications of laryngeal cancer include airway obstruction, neck disfigurement, and speaking difficulties. The prognosis varies with the type and stage of laryngeal cancer. Stage 4 squamous cell carcinoma of larynx has the most unfavorable prognosis.
Staging
According to the TNM staging system, there are 5 stages of laryngeal cancer based on the tumor size, lymph node involvement, and distant metastasis.
History and Symptoms
The hallmark of laryngeal cancer is hoarseness. A positive history of neck lump and hoarseness is suggestive of laryngeal cancer. Common symptoms include lump in the neck, dysphagia, and hoarseness.
Physical Examination
Patients with laryngeal carcinoma are usually well appearing. Physical examination of patients with laryngeal carcinoma is usually remarkable for neck swelling, hearing loss, and stridor.
CT
Head and neck CT scan may be helpful in the diagnosis of laryngeal cancer. Findings on CT scan suggestive of laryngeal cancer include solid soft tissue nodule, region of superficial thickening with increased enhancement, and obliteration of fat planes.
MRI
MRI may be helpful in the diagnosis of laryngeal cancer. Findings on MRI suggestive of laryngeal cancer include intermediate to low signal mass and soft tissue enhancement.[6]
Other Imaging Findings
Other diagnostic studies for laryngeal cancer include laryngoscopy, which demonstrates tumor size and location. Small sessile or superficially spreading lesions can be difficult or impossible to diagnose. Fluoro-D-glucose positron emission tomography may be performed to detect metastases of laryngeal cancer.[1]
Other Diagnostic Studies
Biopsy may be diagnostic of laryngeal cancer. Findings on biopsy diagnostic of laryngeal cancer include spindle cells, basaloid cells, and nuclear atypia.
Medical Therapy
The optimal therapy for laryngeal cancer depends on the stage at the time of diagnosis.
Surgery
The feasibility of surgery depends on the stage of laryngeal cancer at the time of diagnosis.[6]
Primary Prevention
Effective measures for the primary prevention of laryngeal cancer include smoking cessation and limiting or avoiding alcohol consumption.
Secondary Prevention
Secondary prevention measures of laryngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.[7]
References
- ↑ 1.0 1.1 1.2 Protocol applies to all invasive carcinomas of the larynx, including supraglottis, glottis, and subglottis.http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Larynx_11protocol.pdf. Accessed on: October 28, 2015.
- ↑ 2.0 2.1 2.2 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
- ↑ 3.0 3.1 SEER Stat Fact Sheets: Larynx Cancer
- ↑ 4.0 4.1 "Annual Report on the Rare Diseases and Conditions Research". Retrieved 2007-03-22. Unknown parameter
|publsiher=ignored (|publisher=suggested) (help) - ↑ 5.0 5.1 Cancer research UK
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 Hypopharyngeal cancer treatment. National Cancer Institute. http://www.cancer.org/cancer/laryngealandhypopharyngealcancer/detailedguide/laryngeal-and-hypopharyngeal-cancer-risk-factors. Accessed on October 26, 2015.
- ↑ Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.